Cargando…
COVID-19 Vaccine-Induced Pneumonitis, Myositis and Myopericarditis
A 63-year-old male, with no significant past history and not on any regular medications previously, had mild respiratory symptoms post the first dose of the AstraZeneca (Cambridge, England) coronavirus disease 2019 (COVID-19) vaccine, which were self-limiting. Following the second dose of the vaccin...
Autores principales: | Farooq, Mariya, Mohammed, Yaser, Zafar, Mansoor, Dharmasena, Dawpadee, Rana, Usman Iqbal, Kankam, Osei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733846/ https://www.ncbi.nlm.nih.gov/pubmed/35004093 http://dx.doi.org/10.7759/cureus.20979 |
Ejemplares similares
-
Still's Disease and Myopericarditis
por: Kumar, Manish, et al.
Publicado: (2019) -
The Myth of Colchicine in Treating Myopericarditis: Case Report and Literature Review
por: Al-Zakhari, Rana, et al.
Publicado: (2020) -
Myopericarditis as a Manifestation of Long COVID Syndrome
por: Vera-Lastra, Olga, et al.
Publicado: (2021) -
COVID-19-Induced Myopericarditis Leading to Cardiac Tamponade: An Unusual Case Presentation
por: Shah, Niel, et al.
Publicado: (2022) -
Acute Myopericarditis in the Post COVID-19 Recovery Phase
por: Rivera-Morales, Mark D, et al.
Publicado: (2020)